Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis
2008-003633-24Phase 2Active
- Sponsor
- Unidad de Investigación en Tuberculosis de Barcelona
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of rifapentine in pulmonary tuberculosis (TB) (2 arms), sponsored by Unidad de Investigación en Tuberculosis de Barcelona. Primary endpoint: Sputum culture conversion at 8 weeks. Started Aug 2008; status: active.
02
Drugs
rifapentine
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on 2008-003633-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003633-24.